GL1X · GenesisL1 explorer

Research workbench

Vaccine-elicited mouse fp-targeting neutralizing antibody VFP49.02 in complex with HIV fusion peptide (residue 512-519)

Analyse Vaccine-elicited mouse fp-targeting neutralizing antibody VFP49.02 in complex… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6X7W
Type
protein
Length
885 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Ligands
ACE, SO4

Structure

x-ray diffraction · 4 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein222——
G, D—protein8——
H—protein221——
L, C—protein213——

Ligands and binding sites

  • ACE · Acetyl group · ligand · chains G, H, L
  • SO4 · Sulfate ion · ion · 2 copies · chains L, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6X7W · Vaccine-elicited mouse FP-targeting neutralizing antibody vFP49.02 in complex with HIV… · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.